Global Healthcare Today
SEE OTHER BRANDS

The latest news on healthcare and wellness

Global Healthcare Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Healthcare Today.

Press releases published on August 20, 2025

Oncology Biosimilars Market to Hit USD 24 Billion by 2035 | Sandoz, Pfizer, Celltrion Lead – Fact.MR
Global Enzymes Market Set to Reach $20.4 Billion by 2029 | Asia-Pacific Emerges as a Hotspot
Peer-Reviewed Study Demonstrates Improved Sensitivity of mNGS Using Host Depletion Filtration
Dr. Stephen Stahl to Headline Psych Congress 2025 Keynote Panel on Decriminalizing Mental Illness
RxTran Ensures Compliance With Prescription Label Translation Requirements Under Washington State’s ESHB 1852
 George Mason University College of Public Health becomes first in Virginia to earn CEPH accreditation
Mobile imaging market size expected to hit USD 53.84 billion by 2031, expanding at a CAGR of 6.5%.
Bell Integration Seeks to Make Food Storage Safer for the Hospitality Sector
Alice's Wellness Launches 'Back to School, Back to You' Campaign for Adult Mental Health and Wellness
3D printing in healthcare market set to hit $5.84 billion worldwide by 2030, advancing at a 20.1% CAGR.
By 2030, the electrophysiology market is anticipated to witness robust growth at a CAGR of 14.4%.
NTOCC DC Summit Unites Leaders to Create First-Ever Transitions of Care Roadmap and to Launch New Podcast, 'The Relay'
Larkspur Biosciences Announces Discovery of LRK-4189, a First-in-Class Degrader of the Lipid Kinase PIP4K2C, for the Treatment of Microsatellite Stable (MSS) Colorectal Cancer at the ACS Fall 2025 Meeting
BioAge Labs to Present at Upcoming Investor Conferences
Olema Oncology to Participate in Upcoming Investor Conferences
Onco360® Has Been Selected as a Specialty Pharmacy Partner for HERNEXEOS® (zongertinib)
Outset Medical to Present at the 23rd Annual Morgan Stanley Global Healthcare Conference
Sana Biotechnology Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares
NurExone Biologic Announces Preclinical Evidence of Structural Repair in Injured Spinal Cord Tissue following ExoPTEN Treatment
Rhythm Pharmaceuticals Announces FDA Acceptance of sNDA for Setmelanotide in Acquired Hypothalamic Obesity

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions